Acuta Capital Partners, LLC Top Holdings and 13F Report (2026) About Acuta Capital Partners, LLCInvestment ActivityAcuta Capital Partners, LLC has $143.49 million in total holdings as of June 30, 2026.Acuta Capital Partners, LLC owns shares of 23 different stocks, but just 13 companies or ETFs make up 80% of its holdings.Approximately 23.34% of the portfolio was purchased this quarter.About 30.43% of the portfolio was sold this quarter.This quarter, Acuta Capital Partners, LLC has purchased 26 new stocks and bought additional shares in 9 stocks.Acuta Capital Partners, LLC sold shares of 6 stocks and completely divested from 8 stocks this quarter.Largest Holdings PRAXIS PRECISION MEDICINES I $27,719,273Aadi Bioscience $21,461,477Tango Therapeutics $12,221,066SUTRO BIOPHARMA INC $8,972,333ARRIVENT BIOPHARMA INC $7,597,430 Largest New Holdings this Quarter 04272N102 - ARRIVENT BIOPHARMA INC $7,597,430 Holding35104E100 - 4D Molecular Therapeutics $6,753,753 Holding05348Y105 - AVALYN PHARMA INC $3,785,800 Holding04317A107 - ARTIVA BIOTHERAPEUTICS INC $2,526,035 Holding21217B100 - CONTINEUM THERAPEUTICS INC-A $1,034,127 Holding Largest Purchases this Quarter ARRIVENT BIOPHARMA INC 218,694 shares (about $7.60M)4D Molecular Therapeutics 507,801 shares (about $6.75M)Aadi Bioscience 1,275,510 shares (about $5.84M)AVALYN PHARMA INC 115,000 shares (about $3.79M)ARTIVA BIOTHERAPEUTICS INC 260,416 shares (about $2.53M) Largest Sales this Quarter Erasca 89,376 shares (about $1.64M)Tango Therapeutics 50,882 shares (about $1.59M)BRIGHT MINDS BIOSCIENCES INC 19,251 shares (about $1.35M)PRAXIS PRECISION MEDICINES I 2,105 shares (about $704.73K)Ocular Therapeutix 59,627 shares (about $585.54K) Sector Allocation Over TimeMap of 500 Largest Holdings ofAcuta Capital Partners, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorPRAXIS PRECISION MEDICINES I$27,719,273$704,733 â–¼-2.5%82,79619.3%COM NEWAADIAadi Bioscience$21,461,477$5,841,836 â–²37.4%4,685,91215.0%HealthcareTNGXTango Therapeutics$12,221,066$1,590,571 â–¼-11.5%390,9498.5%HealthcareSUTRO BIOPHARMA INC$8,972,333$27,423 â–²0.3%270,2516.3%COMARRIVENT BIOPHARMA INC$7,597,430$7,597,430 â–²New Holding218,6945.3%COMFDMT4D Molecular Therapeutics$6,753,753$6,753,753 â–²New Holding507,8014.7%HealthcareBRIGHT MINDS BIOSCIENCES INC$6,510,699$1,351,420 â–¼-17.2%92,7454.5%COM NEWOCULOcular Therapeutix$5,228,963$585,537 â–¼-10.1%532,4813.6%HealthcareERASErasca$4,858,446$1,637,368 â–¼-25.2%265,1993.4%HealthcareSURROZEN INC$4,499,600$14,221 â–²0.3%173,3953.1%COM NEWARGXargenex$4,365,158$13,917 â–²0.3%4,7053.0%HealthcareMLTXMoonLake Immunotherapeutics$4,198,744$465,177 â–²12.5%215,6522.9%HealthcareDSGNDesign Therapeutics$4,088,701$1,977,528 â–²93.7%282,5642.8%HealthcareNERVMinerva Neurosciences$3,937,7250.0%709,5002.7%HealthcareTSHATaysha Gene Therapies$3,825,912$833,163 â–²27.8%561,8082.7%HealthcareAVALYN PHARMA INC$3,785,800$3,785,800 â–²New Holding115,0002.6%COM SHSAVALO THERAPEUTICS INC$3,442,972$2,319,240 â–²206.4%186,3082.4%COM NEWAMLXAmylyx Pharmaceuticals$3,019,345$306,182 â–²11.3%168,1152.1%HealthcareARTIVA BIOTHERAPEUTICS INC$2,526,035$2,526,035 â–²New Holding260,4161.8%COMCMPXCompass Therapeutics$1,303,516$555,960 â–¼-29.9%595,2130.9%HealthcareUTHRUnited Therapeutics$1,205,0300.0%2,2240.8%HealthcareCONTINEUM THERAPEUTICS INC-A$1,034,127$1,034,127 â–²New Holding63,0950.7%CL ALB PHARMACEUTICALS INC$938,5660.0%28,9190.7%COM SHSTERNTerns Pharmaceuticals$0$26,137,100 â–¼-100.0%00.0%HealthcareOCSOculis$0$2,614,834 â–¼-100.0%00.0%HealthcareRVMDRevolution Medicines$0$2,535,210 â–¼-100.0%00.0%Healthcare4D MOLECULAR THERAPEUTICS INC$0$2,255,394 â–¼-100.0%00.0%COMIDYAIDEAYA Biosciences$0$1,607,157 â–¼-100.0%00.0%HealthcareTRDAEntrada Therapeutics$0$1,127,698 â–¼-100.0%00.0%HealthcareMAZE THERAPEUTICS INC$0$577,150 â–¼-100.0%00.0%COMUNICYCIVE THERAPEUTICS INC$0$381,370 â–¼-100.0%00.0%COMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
